Differential mitogenic responses of human macrovascular and microvascular endothelial cells to cytokines underline their phenotypic heterogeneity

Cell Proliferation

Volumn 34, Issue 3, 2001, Pages 143-155

  Lang, I ^a   Hoffmann, C ^a   Olip, H ^a   Pabst, M A ^a   Hahn, T ^a   Dohr, G ^a   Desoye, G ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CYTOKINE; FIBROBLAST GROWTH FACTOR 2; GROWTH FACTOR; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL DENSITY; CELL HETEROGENEITY; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MITOGENESIS; OPTICAL DENSITY; PHENOTYPE; UMBILICAL VEIN;

CAPILLARIES; CELL DIVISION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; FIBROBLAST GROWTH FACTOR 2; GENETIC HETEROGENEITY; HUMANS; LYMPHOKINES; NEOVASCULARIZATION, PHYSIOLOGIC; PHENOTYPE; UMBILICAL VEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035009980     PISSN: 09607722     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2184.2001.00205.x     Document Type: Article

References (41)

1. Role of VEGF receptor-1 (fit-1) in mediating calcium-dependent nitric oxide release and limiting DNA synthesis in human trophoblast cells
2. Physiological Aspects. Heterogeneity of the endothelial cell
3. Synthesis and physiological activity of heterodimers comprising different splice forms of vascular endothelial growth factor and placenta growth factor
4. Placenta growth factor: Identification and characterization of a novel isoform generated by RNA alternative splicing
5. 2+ mobilization in human umbilical vein endothelial cells
6. Characterization of vascular endothelial cell growth factor interactions with the kinase insert domain-containing receptor tyrosine kinase. A real time kinetic study
7. Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin
8. Purification and characterization of a naturally occurring vascular endothelial growth factor, placenta growth factor heterodimer
9. Molecular and biological properties of the vascular endothelial growth factor family of proteins
10. The vascular endothelial growth factor family of polypeptides
11. Modulation of apoptotic cell death by extracellular matrix proteins and a fibronectin-derived antiadhesive peptide
12. Heterogeneity of endothelial cells. Specific markers
13. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase Akt signal transduction pathway - Requirement for Flk-1/KDR activation
14. A novel technique for culture of human dermal microvascular endothelial cells under either serum-free or serum-supplemented conditions: Isolation by panning and stimulation with vascular endothelial growth factor
15. A heparin-binding form of placenta growth factor (PIGF-2) is expressed in human umbilical vein endothelial cells and in placenta
16. The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency
17. Hypoxia down-regulates placenta growth factor expression: Molecular evidence for "placental hyperoxia" in intrauterine growth restriction
18. Localization of placenta growth factor (PLGF) in human term placenta
19. Regulation of distinct steps of angiogenesis by different angiogenic molecules
20. Heterogeneous histochemical reaction pattern of the lectin Bandeiraea (Griffonia) simplicifolia with blood vessels of human full term placenta
21. Immunohistochemical evidence for the heterogeneity of maternal and fetal vascular endothelial cells in human full-term placenta
22. Two alternative mRNAs coding for the angiogenic factor, placental growth factor (PLGF) are transcribed from a single gene of chromosome 14
23. A critical assessment of the use of microculture tetrazolium assays to measure cell growth and function
24. Neuropilin-1 is a placenta growth factor-2 receptor
25. Glioblastoma growth inhibited in vivo by a dominant-negative flk-1 mutant
26. High affinity VEGF binding and developmental expression suggests flk-1 as a major regulator of vasculogenesis and angiogenesis
27. Vascular endothelial growth factor (VEGF) and its receptors
28. Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and pericytes
29. Placenta growth factor - Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR
30. Flt-1 but not KDR/flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor
31. A unique signal transduction from flt tyrosine kinase, a receptor for vascular endothelial growth factor VEGF
32. 165
33. Fibroblast growth factors as multifunctional signaling factors
34. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
35. The role of phosphatidylinositol 3-kinase in vascular endothelial growth factor signaling
36. Placenta growth factor: Potential role in pregnancy
37. Different signal transduction properties of kdr and flt1, two receptors for vascular endothelial growth factor
38. Vascular permeability factor vascular endothelial growth factor inhibits anchorage-disruption-induced apoptosis in microvessel endothelial cells by inducing scaffold formation
39. Placenta growth factor and vascular endothelial growth factor B and C expression in microvascular endothelial cells and pericytes
40. Differential endothelial migration and proliferation to basic fibroblast growth factor and vascular endothelial growth factor
41. Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic